PT - 日刊文AU - 卡布雷拉，克劳迪娅S. AU - 南，卡桑德拉AU - Lindarck，尼克拉斯AU - 比克曼，马腾J.H.I.AU - Arnetorp, Sofie AU - van der Valk, Ralf J.P. TI - SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β₂-agonist use in asthma AID - 10.1183/13993003.01858-2019 DP - 2020 Feb 01 TA - European Respiratory Journal PG - 1901858 VI - 55 IP - 2 4099 - //www.qdcxjkg.com/content/55/2/1901858.short 4100 - //www.qdcxjkg.com/content/55/2/1901858.full SO - Eur Respir J2020 Feb 01; 55 AB - As SABA overuse is associated with exacerbations and mortality, GINA no longer recommends SABA only as a preferred reliever in asthma. A consistent pattern of high SABA use from the SABINA programme would indicate a global public health issue. http://bit.ly/33XDrlb